WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in IQV — Iqvia Holdings Inc.

CIK 1632972 PLYMOUTH, MN

Position in IQV

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$8,120,650

+$2,522,334 QoQ

Shares Held

42,028

+28.0% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#10

of 107 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 2.5911297230417816.ToString("F0")% Shared 0.ToString("F0")% None 97.40887027695821.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $184,108,370 across 28 Diagnostics & Research names. IQV ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	93,673	$46,963,895
2	DHR	Danaher Corp /De/	139,461	$26,564,531
3	ILMN	Illumina, Inc.	107,790	$18,952,715
4	LH	Labcorp Holdings Inc.	56,094	$15,706,320
5	NTRA	Natera, Inc.	55,459	$15,054,345
6	A	Agilent Technologies, Inc.	103,978	$13,811,397
7	MEDP	Medpace Holdings, Inc.	15,922	$8,432,131
8	IQV	Iqvia Holdings Inc. This page	42,028	$8,120,650

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,120,650	42,028	+28.0%	Shares	Sole	2026-07-15
2026-03-31	$5,598,316	32,827	-8.7%	Shares	Sole	2026-04-08
2025-12-31	$8,105,743	35,960	+35.8%	Shares	Sole	2026-01-08
2025-09-30	$5,029,611	26,480	+30.5%	Shares	Sole	2025-10-29
2025-06-30	$3,197,343	20,289	+53.0%	Shares	Sole	2025-07-10
2025-03-31	$2,337,561	13,259	+34.5%	Shares	Sole	2025-04-16
2024-12-31	$1,937,785	9,861	+83.4%	Shares	Sole	2025-03-17
2024-09-30	$1,274,424	5,378	-0.6%	Shares	Sole	2024-10-24
2024-06-30	$1,144,101	5,411	-8.3%	Shares	Sole	2024-07-16
2024-03-31	$1,491,545	5,898	+5.4%	Shares	Sole	2024-04-15
2023-12-31	$1,295,265	5,598	-92.1%	Shares	Sole	2024-01-30
2023-09-30	$13,949,181	70,898	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.